Pages that link to "Q40005186"
Jump to navigation
Jump to search
The following pages link to Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. (Q40005186):
Displaying 9 items.
- Advances of gene therapy for primary immunodeficiencies (Q26742031) (← links)
- Development of B-lineage Predominant Lentiviral Vectors for Use in Genetic Therapies for B Cell Disorders (Q30498317) (← links)
- Engineering humanized mice for improved hematopoietic reconstitution (Q33844310) (← links)
- Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases (Q34401676) (← links)
- Agammaglobulinemia: causative mutations and their implications for novel therapies (Q38161559) (← links)
- Expression of Tim-1 in primary CNS lymphoma (Q38742256) (← links)
- Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter (Q39033552) (← links)
- Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK. (Q45861548) (← links)
- Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man (Q45870581) (← links)